What You Should Know: - Health equity – or the lack thereof – is one of the biggest challenges facing US healthcare organizations today. - A new report from Accenture, US health inequity: beyond the statistics, analyzes the role US healthcare ecosystem participants can play in addressing health inequities due to race and ethnicity. The statistics are staggering. Analysing Key Trends Concerning Health Inequities To understand the human and economic
Read More
Clinical Research | Clinical Trials & Recruitment | News, Analysis - HIT Consultant
Accelerating Clinical Trials Through AI-Enabled Precision Oncology
The American Cancer Society’s Cancer Statistics 2023 report highlighted a few major accomplishments within oncology, such as decreased cancer mortality rates and increased trial diversity. However, there is still much work to be done. Especially with the multiple types of new and ongoing challenges clinicians and staff members are facing - such as high turnover rates, decreased budgets and increased feelings of burnout - taking the necessary steps to enhance clinical trial procedures is crucial
Read More
5 Key Trends Driving Purchasing Decisions in Healthcare IT
As the healthcare industry continues to evolve and transform with providers facing increasing financial burdens and dynamic patient expectations, Signify Research has had the opportunity to speak to 100s of C-suite health IT executives and departmental decision-makers. Our conversations with these healthcare leaders have provided greater insight into their organizations’ technology and business strategies. It has also illuminated their views on the industry’s most pressing issues. Here are
Read More
Why Clinical Data Research Needs a Makeover in 2023
Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that data accessible for researchers. Unfortunately, the majority of clinical data is based on the same clinical sites and makes conclusions off a limited range of data points. Clinical trials often exclude minorities, rare disease subtypes and other underrepresented populations. Changing the way we gather and share clinical data isn’t easy. Hospitals, biobanks and
Read More
Addressing the Diversity Challenge in Clinical Research Through Patient Advocacy
Diversity is paramount to the success of clinical research, both ethically and scientifically. Without adequate representation of racial and ethnic minorities, investigators lack an understanding of the safety and efficacy of novel treatments within those groups. From a scientific standpoint, an incomplete dataset hinders drug delivery and the development of breakthrough therapies – but from an ethical standpoint, underrepresentation creates a barrier to treatment options for populations that
Read More
5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials
In the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the
Read More
Addressing Health Equity: Practical Solutions to Address Variations in Care
What You Should Know: - The companies and organizations that comprise the Healthcare Leadership Council (HLC), representing all sectors of the American healthcare industry, have joined in a commitment to advance health equity in the United States including principles and actions to ultimately eliminate health disparities. - The joint commitment follows the release late last year of a report developed by HLC and ZS, a global management and technology consulting firm, identifying multiple
Read More
Curebase Launches Remote First DTx Research Platform
What You Should Know: - Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster. - Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market. Making
Read More
Paradigm Launches with $203M to Improve Clinical Research Access
What You Should Know: - Paradigm, a healthcare technology company focused on improving access to clinical research for patients, launched with $203 million in Series A funding. - Conceived by ARCH Venture Partners, and co-incubated by ARCH and General Catalyst, Paradigm is rebuilding the clinical research ecosystem by creating a technology-forward clinical trial platform that enables equitable access for all patients by enhancing trial efficiency and reducing the barriers to participation
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access. There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
